Playback speed
10 seconds
2021 Rheumatology Year in Review: New FDA Approvals and Indications, Biologics for Lupus & GCA, Hydroxychloroquine, IL-23 Inhibitors and JAK Inhibitor Warnings
By
RheumNow
FEATURING
John J. Cush
By
RheumNow
FEATURING
John J. Cush
280 views
January 14, 2022
Login to view comments.
Click here to Login